• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昂丹司琼片的药物研发

Pharmaceutical development of ondansetron tablets.

作者信息

Leak R E, Woodford J D

机构信息

Glaxo Group Research Ltd., Ware, Hertfordshire, U.K.

出版信息

Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S63-6.

PMID:2533901
Abstract

Ondansetron tablets contain ondansetron base as the hydrochloride dihydrate, lactose, microcrystalline cellulose, starch and magnesium stearate. Tablets sampled at the beginning and end of the compression process have good content uniformity and drug content, showing that there is no segregation or loss of the drug substance during tabletting. The release of drug substance is related to the tablet disintegration time. Tablets with disintegration times of 3 and 10 min release 85% of the drug substance in approximately 6 and 20 min respectively. Satisfactory bioavailability has been demonstrated. The tablets have good stability, and have a shelf life of 2 years when stored below 30 degrees C.

摘要

昂丹司琼片含有作为二水合盐酸盐的昂丹司琼碱、乳糖、微晶纤维素、淀粉和硬脂酸镁。在压片过程开始和结束时取样的片剂具有良好的含量均匀度和药物含量,表明在压片过程中药物没有分离或损失。药物的释放与片剂崩解时间有关。崩解时间为3分钟和10分钟的片剂分别在约6分钟和20分钟内释放85%的药物。已证明具有令人满意的生物利用度。该片剂具有良好的稳定性,在30摄氏度以下储存时保质期为2年。

相似文献

1
Pharmaceutical development of ondansetron tablets.昂丹司琼片的药物研发
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S63-6.
2
Pharmaceutical development of ondansetron injection.昂丹司琼注射液的药物研发
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S67-9.
3
Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.采用不同超崩解剂的昂丹司琼口崩片的制备及体内评价。
Arch Pharm Res. 2011 Nov;34(11):1945-56. doi: 10.1007/s12272-011-1115-y. Epub 2011 Dec 3.
4
[Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].[盐酸昂丹司琼缓释片的制备及其体外释药行为评价]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Jun;23(3):597-600, 614.
5
The clinical pharmacology of ondansetron.昂丹司琼的临床药理学。
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S21-4; discussion S25-7.
6
Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.通过化学成像测量药物片剂中密度和压片力的分布。
J Pharm Biomed Anal. 2008 Sep 10;48(1):1-7. doi: 10.1016/j.jpba.2008.04.020. Epub 2008 Apr 26.
7
Evaluation of drug physical form during granulation, tabletting and storage.制粒、压片及储存过程中药物物理形态的评估。
Int J Pharm. 2004 May 4;275(1-2):29-39. doi: 10.1016/j.ijpharm.2004.01.042.
8
Cyclodextrin polymer, a new tablet disintegrating agent.环糊精聚合物,一种新型片剂崩解剂。
Pharmazie. 1984 Jul;39(7):473-5.
9
Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.了解离子化和非离子化壳聚糖的反常效应机制:盐酸昂丹司琼口腔崩解片。
Pharm Dev Technol. 2009;14(5):476-84. doi: 10.1080/10837450902749279.
10
Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.开发和评价一种止吐药昂丹司琼的颊黏膜黏附片剂。
AAPS PharmSciTech. 2009;10(4):1085-92. doi: 10.1208/s12249-009-9304-4. Epub 2009 Sep 9.